Peripheral T cell lymphoma, not otherwise specified (PTCL‐NOS). A new prognostic model developed by the International T cell Project Network [PDF]
, 2018 Carson, Kenneth, et al,
core +2 more sources
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial [PDF]
, 2007 Andrea Gallamini +15 more
openalex +1 more source
Therapeutic targeting of chromatin alterations in leukemia and solid tumors
International Journal of Cancer, EarlyView.Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner +7 more
wiley +1 more source
Peripheral T-Cell Lymphoma: What's Next? [PDF]
Hematol OncolYoon SE, Kim WS.
europepmc +1 more source
Optimizing management of stage IV EGFR mutant non‐small cell lung cancer in Asia: An expert opinion
International Journal of Cancer, EarlyView.What's New? Emerging strategies for the treatment of advanced non‐small cell lung cancer (NSCLC) featuring epidermal growth factor receptor (EGFR) mutations are helping improve patient outcomes. Which strategies are optimal to effectively manage EGFR‐mutant NSCLC, however, remains unclear.
Gee‐Chen Chang +13 more
wiley +1 more source
Nodal Peripheral T-Cell Lymphoma: Therapeutic Challenges and Future Perspectives. [PDF]
Cancers (Basel)Lam HPJ, Amin F, Arulogun SO, Gleeson M.
europepmc +1 more source
Controversies in Lymphoma: The Role of Hematopoietic Cell Transplantation for Mantle Cell Lymphoma and Peripheral T Cell Lymphoma [PDF]
, 2007 Peter Dreger, Ginna G. Laport
openalex +1 more source
CD86, the double agent: Significance of CD86 expression in B‐cell malignancies
International Journal of Cancer, EarlyView.Abstract Bypassing the anti‐tumor functions of the immune system is one of the keys to tumor survival. Tumors, especially hematological tumors, produce or express factors that retune T and B cells to inhibit the immune response. Coreceptors CD28 and CTLA‐4, and their ligands, CD80 and CD86, are involved in the immunological synapse and play an ...
Gábor Barna +4 more
wiley +1 more source
Unusual peripheral T-cell lymphoma with a cytotoxic phenotype presenting in the pancreas. [PDF]
Ann HematolDubois J +8 more
europepmc +1 more source